| Literature DB >> 30100711 |
Huong Thi Thu Nguyen1,2, Mackenzie Pi Moir3, Thanh Xuan Nguyen2,4, Anh Phuong Vu5, Long Hoang Luong2,4, Tam Ngoc Nguyen1,2, Long Hoang Nguyen6, Bach Xuan Tran7,8, Tung Thanh Tran9, Carl A Latkin8, Melvyn Wb Zhang10, Roger Cm Ho11, Huyen Thanh Thi Vu1,2.
Abstract
BACKGROUND: Health-related quality of life (HRQoL) is an important indicator for designing care and treatment services for patients with diabetes. This is especially true given its rapid increase among the elderly population in Vietnam. HRQoL data in elderly diabetic Vietnamese are currently limited. This study aimed to 1) measure the HRQoL of elderly patients with type 2 diabetes (T2DM) in Vietnam and 2) identify related factors and their relationship with HRQoL. PATIENTS AND METHODS: A cross-sectional study was conducted. We recruited 171 patients aged ≥60 years with T2DM at the Outpatient Department, National Geriatric Hospital from June to November 2015. Patients were asked to evaluate their health status using the EuroQol Five Dimensions Three Levels (EQ-5D-3L) and the Visual Analog Scale (VAS). Sociodemographic, diabetic treatment, and management characteristics were collected. Multivariate Tobit regression was used to determine which factors were associated with HRQoL, and the strength of this relationship.Entities:
Keywords: Vietnam; diabetes; elder; quality of life
Year: 2018 PMID: 30100711 PMCID: PMC6067618 DOI: 10.2147/PPA.S162892
Source DB: PubMed Journal: Patient Prefer Adherence ISSN: 1177-889X Impact factor: 2.711
Socioeconomic and behavior characteristics of respondents
| n | Percentage | |
|---|---|---|
| Total | 171 | 100.0 |
| Sex, female | 100 | 58.5 |
| Education attainment | ||
| Low education | 57 | 33.4 |
| Medium education | 60 | 35.1 |
| High education | 54 | 31.6 |
| Living location | ||
| Urban area | 162 | 94.7 |
| Rural area | 9 | 5.3 |
| Living with | ||
| Family | 160 | 93.6 |
| Alone | 7 | 4.1 |
| Others | 4 | 2.3 |
| Being taken care by | ||
| Family | 161 | 94.2 |
| Other people | 6 | 3.5 |
| None | 4 | 2.3 |
| Able to pay diabetes treatment | 140 | 81.9 |
| Have health insurance | 170 | 99.4 |
| Smoking | 38 | 22.2 |
| Alcohol use | 138 | 80.7 |
| Comorbidities | ||
| Yes | 159 | 93.0 |
| No | 12 | 7.0 |
| Body mass index categories | ||
| Underweight | 5 | 2.9 |
| Normal | 138 | 80.7 |
| Overweight/obesity | 28 | 16.4 |
|
| ||
|
| ||
| Age (years) | 69.4 | 6.8 |
| EQ-5D index | 0.80 | 0.20 |
| VAS | 57.5 | 14.4 |
Abbreviations: EQ-5D, EuroQol Five Dimensions; VAS, Visual Analog Scale.
Treatment characteristics among respondents
| n | Percentage | |
|---|---|---|
| Duration of diabetes | ||
| <1 year | 7 | 4.1 |
| 1–5 years | 35 | 20.5 |
| 6–10 years | 45 | 26.3 |
| >10 years | 84 | 49.1 |
| Treatment therapy | ||
| OAD | 86 | 50.3 |
| Insulin | 25 | 14.6 |
| OAD and insulin | 56 | 32.7 |
| None | 4 | 2.4 |
| Number of medicines | ||
| <3 | 28 | 16.4 |
| 3–5 | 65 | 38.0 |
| >5 | 78 | 45.6 |
|
| ||
|
| ||
| Fasting plasma glucose (mmol/L) | 7.7 | 2.2 |
| HbA1c (%) | 7.1 | 1.5 |
Abbreviation: OAD, oral anti-diabetic drug.
Diabetes self-management of respondents
| n | Percentage | |
|---|---|---|
| Self-monitoring blood glucose at home | ||
| Yes | 118 | 69.0 |
| No | 53 | 31.0 |
| Frequency of blood pressure monitor | ||
| Always (5 times per week or more) | 73 | 42.7 |
| Often (1–4 times per week) | 42 | 24.6 |
| Rarely (1–3 times per month) | 44 | 25.7 |
| Never | 12 | 7.0 |
| Diet modification | ||
| Yes | 148 | 86.6 |
| No | 23 | 13.5 |
| Frequency of doing physical exercises | ||
| 5 times per week or more | 133 | 77.8 |
| 1–4 times per week | 12 | 7.0 |
| 1–3 times per month | 11 | 6.4 |
| Never | 15 | 8.8 |
| Ever delayed examination | ||
| Yes | 6 | 3.5 |
| No | 165 | 96.5 |
| Forgot to take medicine | ||
| Yes | 29 | 17.0 |
| No | 142 | 83.0 |
Figure 1HRQoL of participants described with the EQ-5D-3L instrument.
Abbreviations: HRQoL, health-related quality of life; EQ-5D-3L, EuroQol Five Dimensions Three Levels.
Figure 2Mean EQ-VAS score for age groups.
Abbreviation: EQ-VAS, EuroQol Visual Analog Scale.
Factors associated with HRQoL among diabetic patients
| EQ-5D index
| VAS
| |||
|---|---|---|---|---|
| Coef | 95% CI | Coef | 95% CI | |
| Sex (male vs female) | 0.22 | 0.11; 0.34 | 4.80 | −0.40; 10.01 |
| Age | −0.01 | −0.02; −0.00 | ||
| Living location (urban vs rural) | 0.33 | 0.13; 0.54 | 12.13 | 1.28; 22.98 |
| Afford diabetic treatment (yes vs no) | 0.16 | 0.01; 0.30 | ||
| Duration of diabetes (vs <1 year) | ||||
| 6–10 years | −0.14 | −0.25; −0.02 | ||
| Treatment modalities (vs none) | ||||
| Insulin | −0.12 | −0.26; 0.01 | −6.71 | −13.87; 0.45 |
| Number of drugs used (vs >5 drugs) | ||||
| <3 drugs | 0.23 | 0.08; 0.38 | 5.19 | −2.22; 12.59 |
| 3–5 drugs | 0.19 | 0.07; 0.30 | 9.77 | 4.14; 15.39 |
| Self-monitoring blood glucose at home (yes vs no) | 0.07 | −0.04; 0.19 | ||
| Having comorbidities (yes vs no) | −10.16 | −19.00; −1.33 | ||
| Frequency of doing exercises (vs none) | ||||
| 1–4 times/week | 0.14 | −0.05; 0.33 | ||
| Forgot to take medicine (no vs yes) | 0.16 | −0.07; 0.39 | ||
| Frequency of monitoring blood pressure (vs none) | ||||
| 1–4 times/week | 0.21 | 0.07; 0.34 | ||
Note:
p<0.05.
Abbreviations: HRQoL, health-related quality of life; EQ-5D, EuroQol Five Dimensions; VAS, Visual Analog Scale; CI, confidence interval.